The current opioid epidemic is linked to the increasing supply of prescription opioid medications. As a result, the United States is currently experiencing alarming overdoses related to opiates, and deaths attributed to opioid overdose rose 3-fold in those 15 to 64 years of age between 1999 and 2014 with 33,091 deaths in 2015 involving opioid drug overdoses [1,2]. These severe, lethal, and preventable consequence of opioid misuse and addiction in both adults and adolescents underscore the importance of improving the existing treatment interventions. Medication-assisted treatment (MAT) for opioid use disorder is a proven, effective treatment for individuals with an opioid use disorder. MAT has been shown to increase treatment retention, and to reduce opioid use, opioid overdoses, risk behaviors that transmit HIV and hepatitis C virus, morbidity and mortality . Psychiatrist must have a clinical understanding of these medications, their mechanism of action, and the experience starting and prescribing to provide care to individuals with opioid use disorder.
- To identify the FDA-approved medications for the treatment of opioid use disorder.
- Determine the significant risks and benefits to each of these FDA approved drugs.
- Review the role in facilitating behavior change among individuals with substance use disorders.
This resource is an archived webinar that provides an overview of all current treatment (residential and drug-free approaches, agonist maintenance, and antagonist maintenance) of opioid-related conditions. It can be used in totality or broken up, either with an in-person lecture or given to residents for self-directed learning specifically discussing the use of FDA approved medications for treatment and management of OUD. Participants will be able to identify three classes of treatment for opioid dependence and compare rates of relapse in opioid-dependent patients treated post-detoxification with or without medications (agonist or antagonist).
This resource is a review article that provides an overview of the current treatment of opioid-related conditions, including both maintenance treatment and management of withdrawal symptoms. It can be used in totality or broken up, either with an in-person lecture or given to residents for self-directed learning specifically discussing the use of FDA approved medications for treatment and management of OUD. This resource is freely accessible via the link provided for both educators and learners and does not require you to create an account and log in to the APA website.
This resource is a slide set that can be used in totality or broken up, either with an in-person lecture or given to residents for self-directed learning specifically discussing the use of methadone as a maintenance treatment for opioid use disorder. This resource is freely accessible via the link provided for both educators and learners.
Evaluation: Documented completion of this resource can be done through attending supervision suggested in this module.